Skip to main content
. 2018 Nov 23;17:41. doi: 10.1186/s12941-018-0290-9

Table 2.

Clinical characteristics and infection risk factors of Haemophilus influenzae with resistance or reduced susceptibility to ciprofloxacin/levofloxacin

Variablesa N Ciprofloxacinc pd
Susceptible Decreased susceptibility
Age (years)
 0–14 162 (40.3%)
 5–59 110 (27.4%)
 ≥ 60 130 (32.3%)
Sex
 Male 256 (63.7%) 250 (63.6%) 6 (66.7%) 1.000
 Female 146 (36.3%) 143 (36.3%) 3 (33.3%) 1.000
Prevalent seasons (months)
 3–5 138 (34.3%)
 6–8 67 (16.7%)
 9–11 54 (13.4%)
 12–2 143 (35.6%)
Underlying diseases
 Chronic obstructive pulmonary disease 60 (14.9%) 58 (14.7%) 2 (22.2%) 0.626
 Hypertension 70 (17.4%) 68 (17.3%) 2 (22.2%) 1.000
 Diabetes 28 (7.0%) 27 (6.9%) 1 (11.1%) 1.000
 Chronic kidney disease 33 (8.2%) 33 (8.4%) 0 (0%) 1.000b
 Cancers 46 (11.4%) 45 (11.5%) 1 (11.1%) 1.000
 Interstitial lung Disease 14 (3.5%) 1 3(3.3%) 1 (11.1%) 0.732
 Bronchiectasia 27 (6.7%)
Causes
 Catch cold or be tired 30 (7.5%) 27 (6.9%) 3 (33.3%) 0.019
 Invasive procedure 27 (6.7%) 24 (6.1%) 3 (33.3%) 0.011
 History of smoking 40 (9.9%) 39 (9.9%) 1 (11.1%) 1.000
Channel of infection
 Community-acquired 372 (92.5%)
 Hospital-acquired 30 (7.5%)
 Hospitalization during previous 3 months 133 (33.1%) 128 (32.6%) 5 (55.6%) 0.147
 Fluoroquinolones use during previous 3 months 5 (1.2%) 7 (1.8%) 2 (22.2%) 0.003
Antimicrobial use during previous 3 months
 Cephalosporins 144 (36.6%) 4 (44.4%) 0.896
 Azithromycin 70 (17.8%) 0 (0%) 0.370b
 Piperacillin 13 (3.3%) 1 (11.1%) 0.732
 Multidrug resistant strains 55 (14.0%) 8 (88.9%) 0.000

a Data are presented as mean ± SD or number of patients (%)

bFisher’s exact test

cNumbers of susceptible and decreased susceptibility are 393 and 9, respectively

dStatistically significant data are in italics